Hanmi Pharm Co. passed the 100 billion won mark in R&D investment for the first time among pharmaceu

Published: 2014-01-15 06:57:00

Updated: 2014-01-15 06:57:00

Hanmi Pharm Co. passed the 100 billion won mark in R&D investment for the first time among pharmaceutical companies listed on KOSPI
(Yakup Shinmoon)

Hanmi Pharm Co. announced that they passed the 100 billion won mark in R&D investment for the first time among pharmaceutical companies listed on KOSPI.

Through the continuous and intensive R&D investment, Hanmi has been operating 29 cases ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.